First Page | Meta Content | |
---|---|---|
Document Date: 2012-01-30 14:36:19Open Document File Size: 124,09 KBShare Result on FacebookCityPortland / Rockville / Kenilworth / /CompanyOptiumHealth Behavioral Solutions / THE OREGON STATE DRUG REVIEW / Vanda Pharmaceuticals Inc / Schering-Plough / DERP Drug Class Review / Sunovion Pharmaceuticals Inc / / /EventFDA Phase / /FacilityFort Lee / OSU COLLEGE of PHARMACY DRUG USE RESEARCH / Oregon State University / Oregon State Hospital / OSU College of Pharmacy With / /IndustryTermfood / /MedicalConditionorthostasis / Major Depressive Disorder / schizophrenia / Dementia / parkinsonism / seizures / severe sexual dysfunction / nausea / nasal congestion / diabetes / Related Psychoses / autistic disorder / orthostatic hypotension / fatigue / akathisia / oral hypoesthesia / Patients With Schizophrenia / Bipolar Affective Disorder / Disruptive Behavior Disorders / tachycardia / dizziness / acute schizophrenia / MS / tardive dyskinesia / adult schizophrenia / agranulocytosis / bipolar disorder / Pervasive Developmental Disorders / akathisia / /MusicAlbumOregon / Salem / /OrganizationAmerican Psychiatric Association / OSU COLLEGE of PHARMACY DRUG USE RESEARCH / Oregon State University / OSU College of Pharmacy With / Oregon State Hospital / /PersonCydreese Aebi / Depressive Disorder / William Nunley / Findings By Ann Hamer / Kathy Sentena / /PositionClinical Pharmacy Coordinator / Associate Medical Director / Director / CareOregon / Major / MANAGEMENT Managing Editor / /Productolanzapine / clozapine / Haloperidol / Iloperidone (Fanapt) / risperidone / Iloperidone4 / Lurasidone6 / Asenapine2 / /ProvinceOrStateOregon / /PublishedMediumthe DERP Drug Class Review / /Technologyalpha / /URLhttp /SocialTag |